Finance

Lists
DNPUF:OTCMKTS
Sumitomo Pharma Co Ltd
US$ ९.७९
०.००%
(०.००) 1D
सेप्टेम्बर १६, १५:४७:५० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DNPUF...
Mkt. cap
६.९३ खरब
Avg. vol.
८३.००
Volume
०.००
52-wk high
US$ १९.२०
52-wk low
US$ ८.४०
Beta
०.३८
Shares outstanding
४४.९२ करोड
No. of employees
३ हजार
Mkt. cap
६.९३ खरब
Avg. vol.
८३.००
Volume
०.००
52-wk high
US$ १९.२०
52-wk low
US$ ८.४०
Beta
०.३८
Shares outstanding
४४.९२ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Bloomberg Government News
Bloomberg Government News
·
४४ मिनेट पहिले
Nasdaq-Listed Lobbying Firm Launches Capitol Hill Oversight Unit
www.marketscreener.com
www.marketscreener.com
·
४५ मिनेट पहिले
Kyivstar to Report 3Q26 Results on November 6, 2026
Bloomberg.com
Bloomberg.com
·
३ घण्टा पहिले
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
Prediction: The S&P 500 Will Hit 10,000 in 2027
Profile
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Wikipedia
About Sumitomo Pharma Co Ltd
CEO-
Employees३.१२ हजार
Founded१८९७ मे १४
HeadquartersOsaka, Osaka, जापान
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१९ खरब
१.२१ खरब
१.०६ खरब
१.२९ खरब
Cost of goods sold
४५.५९ अरब
५५.४४ अरब
५१.२६ अरब
६१.४१ अरब
Cost of revenue
४५.५९ अरब
५५.४४ अरब
५१.२६ अरब
६१.४१ अरब
Research and development expenses
९.३५ अरब
१०.३५ अरब
१६.१२ अरब
११.४३ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४०.९० अरब
४२.९४ अरब
४३.५२ अरब
३९.२४ अरब
Operating expense
-१.०४ अरब
५२.१९ अरब
१.१० खरब
५०.३३ अरब
Total operating expenses
४४.५५ अरब
१.०८ खरब
१.६१ खरब
१.१२ खरब
Operating income
७४.५७ अरब
१३.०० अरब
-५५.८१ अरब
१७.७५ अरब
Other non operating income
-
-
-१.६४ अरब
-
EBT including unusual items
८०.८७ अरब
८.७४ अरब
-१.२० अरब
१८.३० अरब
EBT excluding unusual items
८०.८७ अरब
८.७४ अरब
-५१.०० अरब
१८.३० अरब
Income tax expense
-६.७८ अरब
-८.०० करोड
-३८.३० करोड
१.३० अरब
Effective tax rate
-८.३९%
-०.९२%
३२.०५%
७.०९%
Other operating expenses
-५१.३० अरब
-१.१० अरब
५०.४५ अरब
-३३.७० करोड
Net income
८७.६५ अरब
८.८२ अरब
-८१.२० करोड
१७.०० अरब
Net profit margin
७३.५८%
७.३१%
-०.७७%
१३.१३%
Earnings per share
-
-
-
-
Interest and investment income
५.११ अरब
२५.८० करोड
४.६४ अरब
२.२० अरब
Interest expense
-
-५.१४ अरब
-
-२.०९ अरब
Net interest expenses
५.११ अरब
-४.८८ अरब
४.६४ अरब
१०.७० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७९.८५ अरब
१८.३२ अरब
-५२.४८ अरब
२२.६५ अरब
Gain or loss from assets sale
१.९६ अरब
-
-
-
AI content may include mistakes. Learn more
Google एपहरू